Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...

US v. Skrmetti undermined constitutional guardrails that guarantee rigorous assessment of medical justifications for policies limiting the rights of transgender people and women, creating a need and ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

While recent fertility drug-related announcements by the Trump administration could result in savings for women—especially ...

The No Surprises Act has protected patients from surprise medical bills. However, the law’s incentives for insurers acting as ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

It is essential to weigh the report’s recommendations not only for their technical merit but also for their political ...

Health Affairs' Jeff Byers welcomes Allison Oakes, Chief Research Officer of Trilliant Health, to the pod to discuss ...

The North Carolina State Health Plan experience shows us that large, self-insured employers can work to bend the cost curve ...

Language services are essential for health equity and good patient health outcomes, but recent executive actions threaten to ...

For now, the most reasonable stance is watchful waiting: acknowledging the real problems WISeR seeks to address, recognizing ...

Despite its age, the classic medical adage of “first, do no harm” is precisely the guiding philosophy that artificial ...